Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Dec 2022 |
---|---|---|---|---|
Total reported revenue | — | 4.5B | 4.5B | 4.5B |
Cost of revenue | — | 3.8B | 3.0B | 3.2B |
Gross profit | — | 754.2M | 1.5B | 1.3B |
Operating expense | ||||
Research & development | — | 24.3M | 29.9M | 22.3M |
Selling general and admin | — | 216.8M | -51.1M | 193.9M |
Other operating expenses | — | -752.8M | 748.2M | -740.8M |
Operating income | — | 1.3B | 1.3B | 1.0B |
Non operating interest income | ||||
Income | — | 93.8M | -23.7M | 62.0M |
Expense | — | 4.4M | 78.3M | 30.8M |
Other income expense | — | — | — | — |
Pretax income | — | 1.6B | 1.7B | 1.5B |
Tax provision | — | 319.2M | 288.0M | 256.2M |
Net income | — | 1.3B | 1.4B | 1.2B |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 6.6B | — | — | — |
Diluted average shares | 6.6B | — | — | — |
EBITDA | — | 1.6B | 1.7B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -133.0M | -157.4M | -120.7M |
Preferred stock dividends | — | 0 | 0 | 0 |